|
96 |
What To Do When Your Regulatory Findings Need Quality Risk Management Action
|
sureAssist |
2024-12-26 |
304 |
|
95 |
The cleanroom debate: Epoxy flooring vs raised flooring
|
sureAssist |
2024-12-26 |
335 |
|
94 |
Inadequate Classification leads to Warning Letter
|
sureAssist |
2024-12-26 |
206 |
|
93 |
FDA criticises the Use of pharmaceutical Facilities for industrial Products
|
sureAssist |
2024-12-26 |
208 |
|
92 |
GMP Requirements for Ready to Sterilize (RTS) and Ready to Use (RTU) Containers
|
sureAssist |
2024-12-26 |
235 |
|
91 |
Modular vs panellised: A guide to accelerate cleanroom delivery
|
sureAssist |
2024-12-26 |
223 |
|
90 |
Results of ECA Survey about Artificial Intelligence in Equipment Qualification
|
sureAssist |
2024-12-26 |
169 |
|
89 |
Warning Letter to Indian sterile Manufacturer due to Cross-Contamination and Particles
|
sureAssist |
2024-12-26 |
165 |
|
88 |
FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals
|
sureAssist |
2024-12-26 |
175 |
|
87 |
Warning Letter to US Company due to Lack of Product and Process Control
|
sureAssist |
2024-12-26 |
155 |
